APA-referens (7:e uppl.)

Gao, X., Liu, F., Zhang, B., Ren, T., Zheng, Y., Niu, Z., . . . Sun, Q. (2025). CDC25A inhibition sensitizes melanoma cells to doxorubicin and NK cell therapy. Cell Death and Disease, 16(1), 1. https://doi.org/10.1038/s41419-025-07598-w

Chicago-referens (17:e uppl.)

Gao, Xinyue, et al. "CDC25A Inhibition Sensitizes Melanoma Cells to Doxorubicin and NK Cell Therapy." Cell Death and Disease 16, no. 1 (2025): 1. https://doi.org/10.1038/s41419-025-07598-w.

MLA-referens (9:e uppl.)

Gao, Xinyue, et al. "CDC25A Inhibition Sensitizes Melanoma Cells to Doxorubicin and NK Cell Therapy." Cell Death and Disease, vol. 16, no. 1, 2025, p. 1, https://doi.org/10.1038/s41419-025-07598-w.